[Acute kidney injury: prevention and treatment update].
Yuzawa
Yukio
Y
Hayashi
Hiroki
H
D058186:Acute Kidney Injury / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control* / Q000628:therapy*; D000617:Aminoglycosides / Q000008:administration & dosage / Q000009:adverse effects; D000666:Amphotericin B / Q000008:administration & dosage / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects; D015415:Biomarkers / Q000097:blood / Q000652:urine; D003404:Creatinine / Q000097:blood; D005440:Fluid Therapy; D006801:Humans; D018529:Nutritional Support; D009846:Oliguria; D012015:Reference Standards; D017582:Renal Replacement Therapy; D049994:Sodium Potassium Chloride Symporter Inhibitors / Q000627:therapeutic use; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D015415:Biomarkers; D049994:Sodium Potassium Chloride Symporter Inhibitors; D014662:Vasoconstrictor Agents; D000666:Amphotericin B; D003404:Creatinine